Global Intravenous Immunoglobulin (IVIg) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Report Id

45824

Publisher Name

Global Info Research

Published Date

2/18/2019

No of Pages

120

Market Scenario

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin. Scope of the Report: North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016. North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%. Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. The worldwide market for Intravenous Immunoglobulin (IVIg) is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 11500 million US$ in 2024, from 8120 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Intravenous Immunoglobulin (IVIg) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Baxter Grifols CSL Octapharma Biotest Kedrion Hualan Bio CNBG Shanghai RAAS CBPO LFB Group BPL Sichuan Yuanda Shuyang Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers IVIg Liquid IVIg Powder Market Segment by Applications, can be divided into Immunodeficiency Autoimmune Disease Acute Infection The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Intravenous Immunoglobulin (IVIg) product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Intravenous Immunoglobulin (IVIg), with price, sales, revenue and global market share of Intravenous Immunoglobulin (IVIg) in 2017 and 2018. Chapter 3, the Intravenous Immunoglobulin (IVIg) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Intravenous Immunoglobulin (IVIg) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Intravenous Immunoglobulin (IVIg) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Intravenous Immunoglobulin (IVIg) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Table of Contents 1 Market Overview 1.1 Intravenous Immunoglobulin (IVIg) Introduction 1.2 Market Analysis by Type 1.2.1 IVIg Liquid 1.2.2 IVIg Powder 1.3 Market Analysis by Applications 1.3.1 Immunodeficiency 1.3.2 Autoimmune Disease 1.3.3 Acute Infection 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Baxter 2.1.1 Business Overview 2.1.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 Grifols 2.2.1 Business Overview 2.2.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 CSL 2.3.1 Business Overview 2.3.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 Octapharma 2.4.1 Business Overview 2.4.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Biotest 2.5.1 Business Overview 2.5.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 Kedrion 2.6.1 Business Overview 2.6.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 Hualan Bio 2.7.1 Business Overview 2.7.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.8 CNBG 2.8.1 Business Overview 2.8.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.9 Shanghai RAAS 2.9.1 Business Overview 2.9.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.10 CBPO 2.10.1 Business Overview 2.10.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.11 LFB Group 2.11.1 Business Overview 2.11.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.12 BPL 2.12.1 Business Overview 2.12.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.13 Sichuan Yuanda Shuyang 2.13.1 Business Overview 2.13.2 Intravenous Immunoglobulin (IVIg) Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2018 3.3.2 Top 6 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Intravenous Immunoglobulin (IVIg) Market Analysis by Regions 4.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Regions 4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Regions (2014-2019) 4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Regions (2014-2019) 4.2 North America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 4.3 Europe Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 4.5 South America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 5 North America Intravenous Immunoglobulin (IVIg) by Country 5.1 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Country 5.1.1 North America Intravenous Immunoglobulin (IVIg) Sales and Market Share by Country (2014-2019) 5.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Country (2014-2019) 5.2 United States Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 5.3 Canada Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 5.4 Mexico Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 6 Europe Intravenous Immunoglobulin (IVIg) by Country 6.1 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Country 6.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales and Market Share by Country (2014-2019) 6.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Country (2014-2019) 6.2 Germany Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 6.3 UK Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 6.4 France Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 6.5 Russia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 6.6 Italy Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 7 Asia-Pacific Intravenous Immunoglobulin (IVIg) by Country 7.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Country (2014-2019) 7.2 China Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 7.3 Japan Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 7.4 Korea Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 7.5 India Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 8 South America Intravenous Immunoglobulin (IVIg) by Country 8.1 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Country 8.1.1 South America Intravenous Immunoglobulin (IVIg) Sales and Market Share by Country (2014-2019) 8.1.2 South America Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Country (2014-2019) 8.2 Brazil Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 8.3 Argentina Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 8.4 Colombia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 9 Middle East and Africa Intravenous Immunoglobulin (IVIg) by Countries 9.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 9.3 Turkey Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 9.4 Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 9.5 Nigeria Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 9.6 South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019) 10 Global Intravenous Immunoglobulin (IVIg) Market Segment by Type 10.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (2014-2019) 10.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2014-2019) 10.2 IVIg Liquid Sales Growth and Price 10.2.1 Global IVIg Liquid Sales Growth (2014-2019) 10.2.2 Global IVIg Liquid Price (2014-2019) 10.3 IVIg Powder Sales Growth and Price 10.3.1 Global IVIg Powder Sales Growth (2014-2019) 10.3.2 Global IVIg Powder Price (2014-2019) 11 Global Intravenous Immunoglobulin (IVIg) Market Segment by Application 11.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2014-2019) 11.2 Immunodeficiency Sales Growth (2014-2019) 11.3 Autoimmune Disease Sales Growth (2014-2019) 11.4 Acute Infection Sales Growth (2014-2019) 12 Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024) 12.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2019-2024) 12.2 Intravenous Immunoglobulin (IVIg) Market Forecast by Regions (2019-2024) 12.2.1 North America Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024) 12.2.2 Europe Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024) 12.2.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024) 12.2.4 South America Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024) 12.2.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024) 12.3 Intravenous Immunoglobulin (IVIg) Market Forecast by Type (2019-2024) 12.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2019-2024) 12.3.2 Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Type (2019-2024) 12.4 Intravenous Immunoglobulin (IVIg) Market Forecast by Application (2019-2024) 12.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2019-2024) 12.4.2 Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

Methodology

This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain

research-methodology

Research Tools and Models

  • Top-Down Approach and Bottom-Up Approach
  • QFD Modeling for Market Size and Share Calculation
  • Regression, Variable and Impact Analysis
  • Penetration Modeling

Qualitative Research

  • It comprises briefing about market dynamics and business opportunities and strategies.
  • Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.

Quantitative Research

It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:

  • Identification of market variables and market size derivation
  • Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
  • Evaluation historical market trends and derivation of present and future year-on-year growth trends

Fill below details to get free sample !!

Contact Us
Call Now